SE8101585L - Neringskomposition, samt sett for dess administrering - Google Patents

Neringskomposition, samt sett for dess administrering

Info

Publication number: SE8101585L
Authority: SE; Sweden
Prior art keywords: amino acid; administration; well; tripeptides; dipeptides
Prior art date: 1980-03-14

Application number

SE8101585A

Other languages

Unknown language ( )

English (en)

Other versions

SE454746B (sv

Inventor

Siamak A Adibi

Original Assignee

Siamak A Adibi

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1980-03-14

Filing date

1981-03-12

Publication date

1981-09-15

1981-03-12 Application filed by Siamak A Adibi filed Critical Siamak A Adibi

1981-09-15 Publication of SE8101585L publication Critical patent/SE8101585L/sv

1988-05-30 Publication of SE454746B publication Critical patent/SE454746B/sv

Links

230000035764 nutrition Effects 0.000 title 1
235000016709 nutrition Nutrition 0.000 title 1
108010016626 Dipeptides Proteins 0.000 abstract 3
DHMQDGOQFOQNFH-UHFFFAOYSA-N Glycine Chemical compound NCC(O)=O DHMQDGOQFOQNFH-UHFFFAOYSA-N 0.000 abstract 2
QNAYBMKLOCPYGJ-REOHCLBHSA-N L-alanine Chemical compound C[C@H](N)C(O)=O QNAYBMKLOCPYGJ-REOHCLBHSA-N 0.000 abstract 2
235000004279 alanine Nutrition 0.000 abstract 2
125000000539 amino acid group Chemical group 0.000 abstract 2
239000004475 Arginine Substances 0.000 abstract 1
WHUUTDBJXJRKMK-UHFFFAOYSA-N Glutamic acid Natural products OC(=O)C(N)CCC(O)=O WHUUTDBJXJRKMK-UHFFFAOYSA-N 0.000 abstract 1
239000004471 Glycine Substances 0.000 abstract 1
ONIBWKKTOPOVIA-BYPYZUCNSA-N L-Proline Chemical compound OC(=O)[C@@H]1CCCN1 ONIBWKKTOPOVIA-BYPYZUCNSA-N 0.000 abstract 1
ODKSFYDXXFIFQN-BYPYZUCNSA-P L-argininium(2+) Chemical compound NC(=[NH2+])NCCC[C@H]([NH3+])C(O)=O ODKSFYDXXFIFQN-BYPYZUCNSA-P 0.000 abstract 1
WHUUTDBJXJRKMK-VKHMYHEASA-N L-glutamic acid Chemical compound OC(=O)[C@@H](N)CCC(O)=O WHUUTDBJXJRKMK-VKHMYHEASA-N 0.000 abstract 1
HNDVDQJCIGZPNO-YFKPBYRVSA-N L-histidine Chemical compound OC(=O)[C@@H](N)CC1=CN=CN1 HNDVDQJCIGZPNO-YFKPBYRVSA-N 0.000 abstract 1
AGPKZVBTJJNPAG-WHFBIAKZSA-N L-isoleucine Chemical compound CC[C@H](C)[C@H](N)C(O)=O AGPKZVBTJJNPAG-WHFBIAKZSA-N 0.000 abstract 1
ROHFNLRQFUQHCH-YFKPBYRVSA-N L-leucine Chemical compound CC(C)C[C@H](N)C(O)=O ROHFNLRQFUQHCH-YFKPBYRVSA-N 0.000 abstract 1
KDXKERNSBIXSRK-YFKPBYRVSA-N L-lysine Chemical compound NCCCC[C@H](N)C(O)=O KDXKERNSBIXSRK-YFKPBYRVSA-N 0.000 abstract 1
FFEARJCKVFRZRR-BYPYZUCNSA-N L-methionine Chemical compound CSCC[C@H](N)C(O)=O FFEARJCKVFRZRR-BYPYZUCNSA-N 0.000 abstract 1
COLNVLDHVKWLRT-QMMMGPOBSA-N L-phenylalanine Chemical compound OC(=O)[C@@H](N)CC1=CC=CC=C1 COLNVLDHVKWLRT-QMMMGPOBSA-N 0.000 abstract 1
AYFVYJQAPQTCCC-GBXIJSLDSA-N L-threonine Chemical compound C[C@@H](O)[C@H](N)C(O)=O AYFVYJQAPQTCCC-GBXIJSLDSA-N 0.000 abstract 1
QIVBCDIJIAJPQS-VIFPVBQESA-N L-tryptophane Chemical compound C1=CC=C2C(C[C@H](N)C(O)=O)=CNC2=C1 QIVBCDIJIAJPQS-VIFPVBQESA-N 0.000 abstract 1
KZSNJWFQEVHDMF-BYPYZUCNSA-N L-valine Chemical compound CC(C)[C@H](N)C(O)=O KZSNJWFQEVHDMF-BYPYZUCNSA-N 0.000 abstract 1
ROHFNLRQFUQHCH-UHFFFAOYSA-N Leucine Natural products CC(C)CC(N)C(O)=O ROHFNLRQFUQHCH-UHFFFAOYSA-N 0.000 abstract 1
KDXKERNSBIXSRK-UHFFFAOYSA-N Lysine Natural products NCCCCC(N)C(O)=O KDXKERNSBIXSRK-UHFFFAOYSA-N 0.000 abstract 1
239000004472 Lysine Substances 0.000 abstract 1
241000124008 Mammalia Species 0.000 abstract 1
125000001429 N-terminal alpha-amino-acid group Chemical group 0.000 abstract 1
ONIBWKKTOPOVIA-UHFFFAOYSA-N Proline Natural products OC(=O)C1CCCN1 ONIBWKKTOPOVIA-UHFFFAOYSA-N 0.000 abstract 1
AYFVYJQAPQTCCC-UHFFFAOYSA-N Threonine Natural products CC(O)C(N)C(O)=O AYFVYJQAPQTCCC-UHFFFAOYSA-N 0.000 abstract 1
239000004473 Threonine Substances 0.000 abstract 1
QIVBCDIJIAJPQS-UHFFFAOYSA-N Tryptophan Natural products C1=CC=C2C(CC(N)C(O)=O)=CNC2=C1 QIVBCDIJIAJPQS-UHFFFAOYSA-N 0.000 abstract 1
KZSNJWFQEVHDMF-UHFFFAOYSA-N Valine Natural products CC(C)C(N)C(O)=O KZSNJWFQEVHDMF-UHFFFAOYSA-N 0.000 abstract 1
ODKSFYDXXFIFQN-UHFFFAOYSA-N arginine Natural products OC(=O)C(N)CCCNC(N)=N ODKSFYDXXFIFQN-UHFFFAOYSA-N 0.000 abstract 1
235000009697 arginine Nutrition 0.000 abstract 1
235000005911 diet Nutrition 0.000 abstract 1
230000000378 dietary effect Effects 0.000 abstract 1
235000013922 glutamic acid Nutrition 0.000 abstract 1
239000004220 glutamic acid Substances 0.000 abstract 1
235000014304 histidine Nutrition 0.000 abstract 1
HNDVDQJCIGZPNO-UHFFFAOYSA-N histidine Natural products OC(=O)C(N)CC1=CN=CN1 HNDVDQJCIGZPNO-UHFFFAOYSA-N 0.000 abstract 1
AGPKZVBTJJNPAG-UHFFFAOYSA-N isoleucine Natural products CCC(C)C(N)C(O)=O AGPKZVBTJJNPAG-UHFFFAOYSA-N 0.000 abstract 1
229960000310 isoleucine Drugs 0.000 abstract 1
229930182817 methionine Natural products 0.000 abstract 1
COLNVLDHVKWLRT-UHFFFAOYSA-N phenylalanine Natural products OC(=O)C(N)CC1=CC=CC=C1 COLNVLDHVKWLRT-UHFFFAOYSA-N 0.000 abstract 1
235000013930 proline Nutrition 0.000 abstract 1
239000004474 valine Substances 0.000 abstract 1

Classifications

- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/17—Amino acids, peptides or proteins
- A23L33/18—Peptides; Protein hydrolysates

Landscapes

Life Sciences & Earth Sciences (AREA)
Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Mycology (AREA)
Nutrition Science (AREA)
Molecular Biology (AREA)
Engineering & Computer Science (AREA)
Food Science & Technology (AREA)
Polymers & Plastics (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Coloring Foods And Improving Nutritive Qualities (AREA)
Medicinal Preparation (AREA)

SE8101585A 1980-03-14 1981-03-12 Neringskomposition som utgor en vattenlosning innehallande fran 1 till 20 viktprocent av minst tva oligopeptider, valda bland dipeptider och tripeptider SE454746B (sv)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
US13030980A	1980-03-14	1980-03-14
US06/227,127 US4340592A (en)	1980-03-14	1981-01-26	Nutrient compositions and method of administering the same

Publications (2)

Publication Number	Publication Date
SE8101585L true SE8101585L (sv)	1981-09-15
SE454746B SE454746B (sv)	1988-05-30

Family

ID=26828352

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
SE8101585A SE454746B (sv)	1980-03-14	1981-03-12	Neringskomposition som utgor en vattenlosning innehallande fran 1 till 20 viktprocent av minst tva oligopeptider, valda bland dipeptider och tripeptider

Country Status (9)

Country	Link
US (1)	US4340592A (sv)
AT (1)	AT372281B (sv)
AU (1)	AU543401B2 (sv)
CH (1)	CH646874A5 (sv)
DE (1)	DE3108079C2 (sv)
FR (1)	FR2477843A1 (sv)
GB (1)	GB2071670B (sv)
NL (1)	NL190951C (sv)
SE (1)	SE454746B (sv)

Families Citing this family (38)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
DE3206784C2 (de) *	1982-02-25	1985-05-09	Pfrimmer & Co Pharmazeutische Werke Erlangen Gmbh, 8520 Erlangen	Glutaminhaltige Zubereitungen für orale oder intravenöse Applikation
EP0181342B1 (en) *	1984-03-01	1992-10-28	ERK, Vernon	Method of treating hypertension in vertebrates
JPS61501564A (ja) *	1984-03-01	1986-07-31	ア−ク，バ−ノン	老人の記憶疾患の治療方法
WO1985003872A1 (en) *	1984-03-01	1985-09-12	Vernon Erk	Method of lowering blood sugar level in vertebrates
JPS61501561A (ja) *	1984-03-01	1986-07-31	ア−ク，バ−ノン	脊椎動物における低血糖症を治療する方法
CA1257806A (en) *	1984-11-19	1989-07-25	Siamak A. Adibi	Nutrient compositions
US5034377A (en) *	1984-11-19	1991-07-23	Montefiore Hospital Association Of Western Pennsylvania	Aqueous nutrient compositions comprising oligopeptides
JPS62149619A (ja) *	1985-09-05	1987-07-03	Teijin Ltd	活性型ビタミンｄ３類注射用組成物
DE3601398A1 (de) *	1986-01-18	1987-07-23	Fresenius Ag	Verwendung von oligopeptiden zur behandlung von cerebralen stoerungen
DE68905387T2 (de) *	1988-06-22	1993-10-21	Ajinomoto Kk	Aminosäure-Nahrungsmittelzusammensetzungen.
DE68910126T2 (de) *	1989-03-28	1994-03-31	Kyowa Hakko Kogyo Kk	Nahrungsmittelzusammensetzung.
US5576351A (en) *	1989-12-29	1996-11-19	Mcgaw, Inc.	Use of arginine as an immunostimulator
US5189016A (en) *	1990-05-18	1993-02-23	Clintec Nutrition Co.	Nutrient compositions containing peptides and method for administering the same
US5122515A (en) *	1990-06-19	1992-06-16	Smith Ross C	Nutrient composition containing dipeptides and method for administering the same
DE4022267C2 (de) *	1990-07-12	1994-09-15	Degussa	N-Acyldipeptide und deren Verwendung
US5167957A (en) *	1990-09-06	1992-12-01	Virginia Tech Intellectual Properties, Inc.	Compositions and methods for the treatment of dietary deficiencies
CA2143420C (en) *	1992-12-23	1999-01-19	Phyllis J. B. Acosta	Medical foods for the nutritional support of infant/toddler metabolic diseases
US5326569A (en) *	1992-12-23	1994-07-05	Abbott Laboratories	Medical foods for the nutritional support of child/adult metabolic diseases
JPH06227974A (ja) *	1993-01-29	1994-08-16	Kyowa Hakko Kogyo Co Ltd	栄養組成物
US5891459A (en) *	1993-06-11	1999-04-06	The Board Of Trustees Of The Leland Stanford Junior University	Enhancement of vascular function by modulation of endogenous nitric oxide production or activity
US5378722A (en) *	1993-12-03	1995-01-03	Clintec Nutrition Co.	Nutritional compositions for management of nitrogen metabolism
US20050196470A9 (en) *	1998-04-03	2005-09-08	Wuh Hank C	Method and composition for enhancing sexual desire
AU3221599A (en)	1998-04-03	1999-10-25	Daily Wellness Company, The	Compositions comprising l-arginine, ginseng and gingko biloba for enhancing blood circulation
US7371415B1 (en)	1998-04-03	2008-05-13	The Daily Wellness Company	Method and composition for improving sexual fitness
JP2003501393A (ja) *	1999-06-05	2003-01-14	ザ・ボード・オブ・トラスティーズ・オブ・ザ・レランド・スタンフォード・ジュニア・ユニバーシティ	心臓血管細胞増殖を阻害するための方法および組成物
US7855181B2 (en) *	1999-08-13	2010-12-21	University Of Florida Research Foundation, Inc.	Dipeptides for prevention of muscle breakdown and microbial infection
US6989164B2 (en)	2000-12-22	2006-01-24	The Daily Wellness Company	Method and composition for improving male fertility health
US6497885B2 (en)	2000-12-22	2002-12-24	The Daily Wellness Company	Method and composition for improving fertility health in female and male animals and humans
CN1939529A (zh) *	2002-01-29	2007-04-04	Wyeth公司	用于调节连接蛋白半通道的组合物和方法
WO2005030243A1 (en) *	2003-09-26	2005-04-07	Bristol Myers Squibb Company	Arginyl-glutamine dipeptide for treatment of pathological vascular proliferation
US20060229256A1 (en) *	2003-09-26	2006-10-12	Bristol-Myers Squibb Company	Enternal administration of arginine and glutamine for abnormal vascular proliferation
CA2557814A1 (en) *	2004-03-01	2005-09-15	Lumen Therapeutics, Llc	Compositions and methods for treating diseases
JP5198065B2 (ja) *	2005-09-20	2013-05-15	協和発酵バイオ株式会社	ジペプチド含有経口用組成物
CA2627968A1 (en)	2005-11-11	2007-05-24	V. Ravi Chandran	Acetylated amino acids as anti-platelet agents, nutritional and vitamin supplements
CN101426513B (zh) *	2006-04-21	2013-05-01	株式会社明治	含有肽作为有效成分的组合物
EP2067044B1 (en) *	2006-09-12	2013-07-03	F. Hoffmann-La Roche AG	Anti-drug antibody assay
US8257938B2 (en) *	2009-02-27	2012-09-04	Medical Diagnostic Laboratories, Llc	Hemolysin and its protein fragments in sero-detection of Anaplasma phagocytophilum
CN107744140A (zh) *	2017-11-06	2018-03-02	威海红印食品科技有限公司	一种预消化型全营养液及其制备方法

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
CH591918A5 (sv) *	1974-03-05	1977-10-14	Nestle Sa
CH594367A5 (sv) *	1974-05-17	1978-01-13	Brenner Beat Max
US4024286A (en) *	1976-05-17	1977-05-17	Miles Laboratories, Inc.	Fortification of foodstuffs with C-terminal amino acid substituted methionine dipeptides
US4127534A (en) *	1977-06-16	1978-11-28	Coy David Howard	Novel tripeptides, intermediates therefor and pharmaceutical compositions and methods employing said tripeptides

1981
- 1981-01-26 US US06/227,127 patent/US4340592A/en not_active Expired - Lifetime
- 1981-03-03 GB GB8106648A patent/GB2071670B/en not_active Expired
- 1981-03-04 DE DE3108079A patent/DE3108079C2/de not_active Expired
- 1981-03-04 FR FR8104278A patent/FR2477843A1/fr active Granted
- 1981-03-09 CH CH160081A patent/CH646874A5/de not_active IP Right Cessation
- 1981-03-11 NL NL8101182A patent/NL190951C/xx not_active IP Right Cessation
- 1981-03-12 SE SE8101585A patent/SE454746B/sv not_active IP Right Cessation
- 1981-03-13 AT AT0117581A patent/AT372281B/de not_active IP Right Cessation
- 1981-03-13 AU AU68338/81A patent/AU543401B2/en not_active Ceased

Also Published As

Publication number	Publication date
FR2477843B1 (sv)	1985-03-22
DE3108079C2 (de)	1986-01-16
ATA117581A (de)	1983-02-15
GB2071670B (en)	1983-07-13
US4340592A (en)	1982-07-20
NL190951C (nl)	1994-11-16
FR2477843A1 (fr)	1981-09-18
AT372281B (de)	1983-09-26
GB2071670A (en)	1981-09-23
SE454746B (sv)	1988-05-30
CH646874A5 (de)	1984-12-28
DE3108079A1 (de)	1982-01-21
NL190951B (nl)	1994-06-16
AU6833881A (en)	1981-09-17
NL8101182A (nl)	1981-10-01
AU543401B2 (en)	1985-04-18

Legal Events

Date	Code	Title	Description
1995-01-31	NAL	Patent in force	Ref document number: 8101585-1 Format of ref document f/p: F
1996-06-17	SPCF	Application for supplementary protection certificate filed	Free format text: 9690012, 951122
1997-11-24	SPCG	Supplementary protection certificate granted	Free format text: 9690012, 951122, EXPIRES: 20060312
2001-05-21	NUG	Patent has lapsed	Ref document number: 8101585-1 Format of ref document f/p: F

Publication	Publication Date	Title
Sanger et al.	1951	The amino-acid sequence in the phenylalanyl chain of insulin. 2. The investigation of peptides from enzymic hydrolysates
ATE213389T1 (de)	2002-03-15	Antemortem futterzusatz für lebendes vieh
EP0873754A4 (en)	1999-03-24	AMINO ACID COMPOSITIONS
WO2007133642A8 (en)	2008-01-17	Sport drink containing amino acids and carbohydrates
ATE343332T1 (de)	2006-11-15	Zusammensetzung, welche aminosäuren und trehalose enthält
GB1511302A (en)	1978-05-17	Pharmaceutical compositions comprising amino acid analogues
EP0182356B2 (en)	1998-08-05	Nutrient compositions
MX9703642A (es)	1998-11-29	Metodos para el tratamiento de esclerosis multiple utilizando analogos de peptido en la posicion 91 de la proteina basica de mielina humana.
SE9403526D0 (sv)	1994-10-14	New Peptides
Block et al.	1952	Amino acids in posterior pituitary protein
JPS5594934A (en)	1980-07-18	Peptide type polymer and pharmaceutic composition containing it
ATE31418T1 (de)	1988-01-15	Arzneimittel, welche tripeptide enthalten.
AR009807A1 (es)	2000-05-03	Peptidos que contienen analogos de cisteina.
KR900013872A (ko)	1990-10-22	영양 조성물
GB1460108A (en)	1976-12-31	Pharmaceutical preparations containing aspirin or indomethacin
GB1397680A (en)	1975-06-18	Aqueous lipid emulsion for parenteral alimentation
DE3462692D1 (en)	1987-04-23	Pharmacologically active peptides
AU7196596A (en)	1997-02-06	Peptides and antibodies for treatment of rheumatoid arthritis
CA2099529A1 (en)	1995-01-03	Antemortem nutrient supplement for livestock
EP0610499A4 (en)	1994-07-01	TO INCREASE PROTOGLYCAN, ANTITUMOR IMMUNITY.
Hess et al.	1952	Dentinal protein: amino acid composition.
NO942323L (no)	1994-06-17	Soyaprotein eller hydrolysater i farmasöytiske preparater for beskyttelse av bioaktive peptider mot enzymatisk inaktivering
GB1203301A (en)	1970-08-26	New peptides having an acth-activity
GB1461106A (en)	1977-01-13	Gastric acid-inhibiting polypeptide
EP0361956A3 (en)	1991-07-10	Increased expression of small molecular weight recombinant proteins